KYDRAZZA Trademark

Trademark Overview


On Tuesday, April 6, 2021, a trademark application was filed for KYDRAZZA with the United States Patent and Trademark Office. The USPTO has given the KYDRAZZA trademark a serial number of 90627256. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 4, 2023. This trademark is owned by Travere Therapeutics, Inc.. The KYDRAZZA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
kydrazza

General Information


Serial Number90627256
Word MarkKYDRAZZA
Filing DateTuesday, April 6, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTravere Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameTravere Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Tuesday, September 5, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, February 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 1, 2023SOU EXTENSION 2 GRANTED
Wednesday, February 1, 2023SOU EXTENSION 2 FILED
Wednesday, February 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 27, 2022SOU EXTENSION 1 GRANTED
Wednesday, July 27, 2022SOU EXTENSION 1 FILED
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 29, 2021ASSIGNED TO EXAMINER
Thursday, July 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 9, 2021NEW APPLICATION ENTERED